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Oral administration of Embelia ribes berries (50% EtoH) reduced blood sugar level significantly. 
In intact rats, blood sugar levels were decreased by 13.1% and 20.3% after 3 hrs. and 5 hrs. of 
treatment respectively. While in alloxan induced diabetic rats blood glucose levels were 
decreased after 3 hours and 5hours by 28.1% and 34.5% respectively. Hypoglycaemic action of 
Embelia ribes b e r r i e s  m a y  b e  d u e  t o  i t s  d i r e c t  a c t i o n  o n  t i s s u e  o r  d u e  t o  i n c r e a s e  i n  i n s u l i n  
secretion. 
 




Embelia ribes Burm.f belongs to family 
Myrsinaceae. Almost all parts of this plant 
are used for medicinal purposes1-2. Embelin 
(C17H26O4) is the active principle of this 
plant. In the present study, attempts have 
been made to evaluate the hypoglycaemic 
activity of Embelia ribes berries in alloxan 
induced diabetic rats. 
 
Material and Methods 
 
Healthy adult male albino rats weighing 
190-200 gms were used. They were 
maintained on rat feed and water ad libitum. 
Diabetes was induced by a single 
intraperitoneal injection of alloxan 
monohydrate (150 mg/kg body weight). 
These animals were fed with 50% glucose at 
the dose of 5 ml/animal/5 hours interval 
upto 24 hours. After 72 hours of alloxan 
injection, blood from tail vein was taken in 
dried oxalate fluoride vials and Embelia ribes 
berries (50% EtOH) extract at the dose 500 
mg/kg body weight was administered 
orally.  
 
Twenty animals were divided into four 
groups of five each 
 
Group A : Animals of this group were 
treated as Normoglycaemic control. 
 
Gropup B : Normoglycaemic control + E. 
ribes  berries extract (500 mg/kg body 
weight) 
 
Group C : Animal of this group were 
treated as hyperglycaemic control. 
Hyperglycaemia was induced by 
intraperitoneal injection of alloxan 
monohydrate (150 mg/kg body weight). 
 
Group D: Hyperglycaemic control + E. ribes 
berries extract (500 mg/kg body weight) 
Blood samples were taken at 3 and 6 hours 
after treatment and then blood glucose was 
analysed by the standard kit methods. The 
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result were statistically analysed by 
student‘t’ test.  
 
Result and Discussion 
 
Oral feeding of Embelia ribes berries extract 
(500 mg/kg body weight) reduced blood 
glucose level in normoglycaemic rats by 
13.1% and 20.3% after 3 hours and 6 hours 
of treatment respectively (Gr. B). Similarly, 
E. ribes berries extract caused reduction in 
blood sugar level by 28.1% and 34.5% after 
3 hours and 5 hours of treatment 
respectively in alloxan induced diabetic rats 
(Gr. D). 
 
Decrease in blood glucose concentration 
after  E. ribes berries extract (50% EtOH) 
feeding may be produced by several 
mechanism including decreased synthesis 
or release of glucose by the liver or 
increased secretion of insulin or increased 
peripheral glucose utilization3-8. In 
conclusion,  Embelia ribes berries possesses 
active hypoglycaemic constituents.  
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Table: Mean blood glucose concentration (mg/100 ml)after oral administration of Embelia ribes berries extract in 
normoglycaemic and hyperglycaemic rats 
 
Treatment groups  0 hrs.   3  hrs  after 
treatment  
 %  deviation 
from 0 hrs. 
6 hrs after 
treatment 
% deviation 
from 0 hrs. 
Normoglycaemic control 
(Gr. A) 
91.0 ± 5.1  88.1 ± 7.2  -3.5  87.1 ± 5.2  - 4.4 
Normoglycaemic control + E. ribes 
berries extract (500 mg/kg body 
weight) (Gr. B) 
85.2 ± 1.5  73.1± 2.8
b  -13.1  68.3 ± 8.1
a -20.3 
Hyperglycaemic Control (Gr. C)  422.7 ± 23.7  417 ± 30.2  -1.7  439.7 ± 27.5  4.2 
Hyperglycaemic Control + E. ribes 
berries extract (500 mg/kg body 
weight) (Gr. D) 
601.2 ± 40.1  437.3 ± 27.5
a  -28.1  398.1 ± 41.4
b -34.5 
 
Readings at 3 hours and 6 hours after treatment were compared with 0 hrs. reading. 
 
a P≤ 0.05, 
bP≤0.01 
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